Profile data is unavailable for this security.
About the company
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
- Revenue in USD (TTM)41.64m
- Net income in USD-12.02m
- Incorporated2004
- Employees184.00
- LocationMyomo Inc137 Portland Street, 4Th FloorBOSTON 02114United StatesUSA
- Phone+1 (617) 996-9058
- Fax+1 (302) 655-5049
- Websitehttps://myomo.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adagio Medical Holdings Inc | 137.00k | -79.15m | 22.03m | 86.00 | -- | -- | -- | 160.78 | -4.75 | -4.75 | 0.0087 | -0.0853 | 0.002 | 0.7558 | 3.04 | 1,593.02 | -114.09 | -- | -130.69 | -- | -1,468.61 | -- | -57,771.53 | -- | 0.6798 | -4.93 | 1.07 | -- | 100.67 | -- | -105.09 | -- | -- | -- |
| Jin Medical International Ltd | 20.69m | 1.19m | 22.23m | 295.00 | 18.66 | 0.75 | 13.68 | 1.07 | 0.0076 | 0.0076 | 0.1322 | 0.1893 | 0.4172 | 2.90 | 2.88 | 75,777.59 | 2.79 | 8.21 | 4.72 | 12.72 | 29.22 | 33.56 | 6.68 | 12.52 | 1.65 | -- | 0.3891 | 0.00 | -11.98 | 5.02 | -67.59 | -11.59 | 115.60 | -- |
| IRIDEX Corp | 50.65m | -5.09m | 24.24m | 93.00 | -- | -- | -- | 0.4786 | -0.3026 | -0.3026 | 3.02 | 0.2746 | 1.73 | 3.43 | 7.74 | 544,591.40 | -17.39 | -20.28 | -33.62 | -29.96 | 38.18 | 42.41 | -10.04 | -15.17 | 1.35 | -- | 0.4418 | -- | -6.17 | 2.30 | 6.90 | -- | -36.71 | -- |
| Global Innovative Platforms Inc | 30.00k | -647.22k | 24.24m | 52.00 | -- | 147.33 | -- | 808.04 | -0.0156 | -0.0156 | 0.0007 | 0.0035 | 0.1607 | -- | -- | -- | -346.65 | -- | -441.46 | -- | -- | -- | -2,157.40 | -- | -- | -- | 0.0185 | -- | -- | -- | -427.35 | -- | -- | -- |
| Inspira Technologies Oxy BHN Ltd | 289.00k | -11.21m | 25.96m | 38.00 | -- | 13.45 | -- | 89.84 | -0.4606 | -0.4606 | 0.0128 | 0.0446 | 0.0417 | 0.5281 | 0.6659 | 7,605.26 | -161.61 | -109.16 | -302.02 | -145.38 | 0.692 | -- | -3,879.24 | -- | 0.9002 | -- | 0.00 | -- | -- | -- | 2.06 | -- | 39.54 | -- |
| Harvard Bioscience Inc | 87.37m | -53.84m | 26.43m | 330.00 | -- | 1.87 | -- | 0.3025 | -1.22 | -1.22 | 1.98 | 0.3156 | 0.8352 | 1.58 | 7.01 | 264,760.60 | -51.46 | -4.48 | -81.52 | -5.47 | 56.94 | 57.18 | -61.62 | -6.18 | 0.4081 | -0.5686 | 0.7071 | -- | -16.14 | -4.12 | -263.25 | -- | 21.83 | -- |
| PetVivo Holdings Inc | 1.11m | -10.21m | 27.31m | 24.00 | -- | 7.96 | -- | 24.57 | -0.3857 | -0.3857 | 0.0411 | 0.0981 | 0.2969 | 0.7874 | 4.25 | 46,318.33 | -265.20 | -195.28 | -557.27 | -346.33 | 66.05 | 74.58 | -893.26 | -1,163.49 | 0.787 | -4.52 | 0.00 | -- | 16.91 | 216.08 | 23.33 | -- | 49.21 | -- |
| Myomo Inc | 41.64m | -12.02m | 28.85m | 184.00 | -- | 1.97 | -- | 0.6927 | -0.2885 | -0.2885 | 1.01 | 0.3805 | 1.65 | 3.96 | 9.23 | 226,321.70 | -47.71 | -55.96 | -70.30 | -77.40 | 66.56 | 69.74 | -28.86 | -52.92 | 2.10 | -- | 0.2148 | -- | 69.17 | 53.36 | 24.10 | -- | 92.10 | -- |
| Guided Therapeutics Inc | 178.00k | -2.80m | 29.26m | 4.00 | -- | -- | -- | 164.38 | -0.0386 | -0.0386 | 0.0025 | -0.0675 | 0.1654 | 0.1083 | 44.50 | 44,500.00 | -244.61 | -129.80 | -- | -- | 62.92 | 44.19 | -1,478.65 | -4,184.72 | 0.0334 | -4.13 | -- | -- | -92.86 | -27.93 | 31.07 | -- | -- | -- |
| Femasys Inc | 2.06m | -19.80m | 31.46m | 69.00 | -- | 5.59 | -- | 15.26 | -0.7198 | -0.7198 | 0.07 | 0.0963 | 0.1294 | 0.1973 | 4.34 | 29,876.81 | -124.24 | -63.09 | -214.46 | -74.30 | 63.05 | 66.63 | -960.53 | -961.82 | 0.6131 | -9.72 | 0.5982 | -- | 51.97 | 11.89 | -32.07 | -- | 4.01 | -- |
| Vaso Corp | 89.11m | 2.59m | 31.60m | 298.00 | 12.23 | 1.12 | 9.54 | 0.3546 | 0.0147 | 0.0147 | 0.5065 | 0.1605 | 1.13 | 34.02 | 10.28 | 299,030.20 | 3.27 | 7.37 | 5.36 | 14.56 | 60.91 | 59.17 | 2.91 | 5.99 | 1.61 | -- | 0.01 | -- | 7.09 | 2.82 | -80.21 | -- | 3.81 | -- |
| RenovoRx Inc | 928.00k | -11.11m | 32.32m | 10.00 | -- | 4.00 | -- | 34.83 | -0.4375 | -0.4375 | 0.0312 | 0.2204 | 0.0874 | -- | -- | 92,800.00 | -104.58 | -121.57 | -126.33 | -166.50 | 67.78 | -- | -1,196.66 | -90,830.23 | 5.68 | -- | 0.00 | -- | -- | -- | 13.86 | -- | -- | -- |
| EUDA Health Holdings Ltd | 5.16m | -2.06m | 32.98m | 117.00 | 56.47 | -- | -- | 6.39 | 0.0155 | 0.0876 | 0.1483 | -0.0998 | 2.49 | -- | 17.10 | 44,104.96 | -100.77 | -- | -- | -- | 22.39 | -- | -40.53 | -- | 0.2084 | -46.54 | -- | -- | 8.22 | -- | -108.62 | -- | -- | -- |
| Precision Optics Corporation Inc | 24.42m | -6.92m | 33.66m | 90.00 | -- | 3.61 | -- | 1.38 | -0.9286 | -0.9286 | 3.25 | 1.21 | 1.21 | 5.44 | 5.83 | 271,288.60 | -34.24 | -13.63 | -57.54 | -19.51 | 9.70 | 29.56 | -28.33 | -11.58 | 0.6188 | -36.73 | 0.1454 | -- | -0.0685 | 13.98 | -95.85 | -- | 7.81 | -- |
| Neuroone Medical Technologies Corp | 8.72m | -6.83m | 33.70m | 18.00 | -- | 5.25 | -- | 3.87 | -0.1648 | -0.1648 | 0.1936 | 0.1270 | 1.16 | 2.19 | 3.47 | 484,231.70 | -90.61 | -113.64 | -111.55 | -152.08 | 54.87 | 60.94 | -78.34 | -223.44 | 5.09 | -- | 0.1119 | -- | 250.35 | 44.41 | 70.73 | -- | -7.76 | -- |
| Ekso Bionics Holdings Inc | 12.80m | -11.92m | 36.45m | 50.00 | -- | 4.03 | -- | 2.85 | -5.09 | -5.09 | 5.28 | 2.54 | 0.5474 | 1.27 | 1.76 | 255,980.00 | -50.02 | -37.99 | -76.46 | -49.47 | 53.48 | 52.48 | -91.37 | -86.20 | 1.07 | -- | 0.31 | -- | -28.60 | 7.58 | -5.22 | -- | -- | -- |
Data as of Mar 02 2026. Currency figures normalised to Myomo Inc's reporting currency: US Dollar USD
31.22%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rosalind Advisors, Inc.as of 31 Dec 2025 | 3.84m | 9.99% |
| Horton Capital Management LLCas of 26 Dec 2025 | 1.96m | 5.10% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 1.53m | 3.98% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.34m | 3.49% |
| Geode Capital Management LLCas of 31 Dec 2025 | 736.97k | 1.92% |
| Jefferies Investment Advisers LLCas of 31 Dec 2025 | 704.28k | 1.83% |
| UBS Securities LLCas of 31 Dec 2025 | 559.47k | 1.46% |
| Goldman Sachs & Co. LLC (Private Banking)as of 31 Dec 2025 | 466.71k | 1.21% |
| AQR Capital Management LLCas of 31 Dec 2025 | 434.38k | 1.13% |
| Clearstead Advisors, LLCas of 31 Dec 2025 | 425.60k | 1.11% |
More ▼
Data from 31 Dec 2025 - 13 Feb 2026Source: FactSet Research Systems Inc.
